PMEL Recombinant Antibody, Cy5 Conjugated
Product Specifications
Background
Plays a central role in the biogenesis of melanosomes. Involved in the maturation of melanosomes from stage I to II. The transition from stage I melanosomes to stage II melanosomes involves an elongation of the vesicle, and the appearance within of distinct fibrillar structures. Release of the soluble form, ME20-S, could protect tumor cells from antibody mediated immunity.
Synonyms
PMEL; ME20-M; Premelanosome protein; Silver locus protein homolog; PMEL17; SILV.
Gene ID
6490
Swiss Prot
P40967
Cellular Locus
Extracellular, Secreted
Host
Rabbit
Cross Reactivity
Human
Target
PMEL
Clonality
Recombinant
Isotype
IgG
Conjugation
Cy5
Source
KLH conjugated synthetic peptide derived from human PMEL
Applications
WB, IF
Purification
Purified by Protein A.
Excitation Emission
625,650nm/670nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), IF ()
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
6490
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15398464 1 Vial
Lentiviral human ADIPOR1 sgRNA gene knockout kit - Lentiviral human ADIPOR1 sgRNA gene knockout kit (100)
Ask
View Details GTR15148434 1 Vial
Lentiviral human CPSF4 shRNA (UAS) - Lentiviral human CPSF4 shRNA (UAS) (100)
Ask
View Details A22961-25000 25000 mg
N6- (((9H-Fluoren-9-yl) methoxy) carbonyl) -N2- ((benzyloxy) carbonyl) -L-lysine 25g
Ask
View Details